Lalaine B. Villaflor-Oida, Raymond L. Rosales, Ma. Antonia Aurora M. Valencia, Michelle G. Sy, Yuh-Jyh Jong
Apr 2023 DOI 10.35460/2546-1621.2022-0025 Access
Spinal muscular atrophy (SMA) is the most common inherited lethal disease in children. Confirmatory diagnosis is based on molecular genetic testing of survival motor neuron (SMN) genes. We aimed to describe the phenotypic presentation of Filipino infants and children with SMA based on the copy number analysis of SMN genes. Medical records of 17 Filipino children were reviewed from January 2017 to December 2019. De-identified clinical data fulfilled the diagnostic criteria defined by the International SMA Consortium.
Among Filipino children, the predominant SMA type by copy number was type I having two copies of SMN2 gene. The clinical severity based on symptom onset and highest functional motor capacity attained correlated with SMN2 copy number congruent with existing data. A significant time lag between symptom onset to confirmation of genetic diagnosis was noted. Nine out of the 17 (52%) children did not have a family history of the disease, raising the possibility of mutation carriers in these families since the incidence of de novo mutations in literature is about 2%.
These data offered the first epidemiological pattern of genetically confirmed SMA among Filipino children; provided additional information for genetic counselling; and an avenue to consider pre-symptomatic newborn screening and carrier testing that would change proactive measures and opportunities for therapy. These measures unavoidably will decrease the incidence and prevalence of disease in the future.
Key words: Clinical profile, spinal muscular atrophy, genetically-confirmed, Filipino children, survival motor neuron
- Swaiman K. Swaiman's Pediatric Neurology (6th Ed). Amsterdam: Elsevier; 2018.
- Wadman RI, Stam M, Gijzen M, Lemmink HH, Snoeck IN, Wijngaarde CA, et al. Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4. J Neurol Neurosurg Psychiatry [Internet]. 2017;88(4):365–7. Available from: http://dx.doi.org/10.1136/jnnp-2016-314292
- Prior TW, Nagan N, Sugarman EA, De Batish S V., Braastad C. Technical standards and guidelines for spinal muscular atrophy testing. Genet Med [Internet]. 2011;13(7):686–94. Available from: http://dx.doi.org/10.1097/gim.0b013e318220d523
- ICD 10 registry - Philippine Pediatric Society, Inc. [Internet]. Philippine Pediatric Society, Inc. - A Specialty Division of the Philippine Medical Association (PMA). 2022 [cited 2022 Nov 21]. Available from: https://pps.org.ph/council-and-committees/council-on-research-publications/icd-10-registry/
- Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord [Internet]. 2018;28(2):103–15. Available from: http://dx.doi.org/10.1016/j.nmd.2017.11.005
- Feng Y, Ge X, Meng L, Scull J, Li J, Tian X, et al. The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing. Genet Med [Internet]. 2017;19(8):936–44. Available from: http://dx.doi.org/10.1038/gim.2016.215
- Harada Y, Sutomo R, Sadewa AH, Akutsu T, Takeshima Y, Wada H, et al. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severity. J Neurol [Internet]. 2002;249(9):1211–9. Available from: http://dx.doi.org/10.1007/s00415-002-0811-4
- Hendrickson BC, Donohoe C, Akmaev VR, Sugarman EA, Labrousse P, Boguslavskiy L, et al. Differences in SMN1 allele frequencies among ethnic groups within North America. J Med Genet [Internet]. 2009;46(9):641–4. Available from: http://dx.doi.org/10.1136/jmg.2009.066969
- Lin C-W, Kalb SJ, Yeh W-S. Delay in diagnosis of spinal muscular atrophy: A systematic literature review. Pediatr Neurol [Internet]. 2015;53(4):293–300. Available from: http://dx.doi.org/10.1016/j.pediatrneurol.2015.06.002
Articles related to the one you are viewing
There are currently no results to show, please try again later
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.